Shockwave Therapy for Patellar Tendinopathy

What Is Patellar Tendinopathy?

You push off to jump and a sharp, focused pain bites into the front of your knee, right at the bottom edge of the kneecap. Landing hurts even more. Squatting, lunging, climbing stairs — anything that loads the knee in a bent position — triggers the same spot. You can point to it with one finger. It has been there for weeks or months, and it is not going away.

Patellar tendinopathy, commonly called jumper’s knee, is a chronic overuse condition affecting the patellar tendon — the thick band of tissue that connects the kneecap (patella) to the shinbone (tibial tuberosity). The pain is almost always localized to the inferior pole of the patella, where the tendon attaches to the kneecap. The condition is most common in athletes involved in sports that require repetitive jumping and landing — basketball, volleyball, track and field, and soccer — with prevalence rates as high as 45% in elite volleyball players and 32% in elite basketball players.

But jumper’s knee is not limited to athletes. Anyone who repeatedly loads the patellar tendon through squatting, stair climbing, or running can develop the condition. Like other chronic tendinopathies, patellar tendinopathy is a degenerative process characterized by collagen disorganization, increased ground substance, and neovascularization in the tendon — not active inflammation. The tendon has essentially failed to heal from repetitive micro-damage, and it has entered a cycle of degeneration that standard rest and anti-inflammatory treatments rarely break. This is where shockwave therapy offers a meaningful non-surgical option.

How Shockwave Therapy Works for Patellar Tendinopathy

Extracorporeal shockwave therapy (ESWT) targets the degenerated patellar tendon tissue with focused acoustic energy, aiming to restart the stalled healing process that characterizes chronic tendinopathy.

The patellar tendon at its attachment to the inferior pole of the patella is subjected to enormous forces during jumping and landing — up to 8 times body weight. In tendinopathy, the tissue at this high-stress zone develops areas of mucoid degeneration, where normal collagen fibers are replaced by disorganized, weakened tissue. Shockwave therapy delivers controlled mechanical energy directly into these degenerative zones.

This mechanical stimulus triggers several key biological responses. First, it promotes the proliferation and activation of tenocytes (tendon cells), which begin producing new, organized collagen to replace the degenerative tissue. Second, shockwave energy stimulates the release of growth factors — including transforming growth factor beta-1 (TGF-B1) and insulin-like growth factor-1 (IGF-1) — that are essential for tendon repair. Third, ESWT promotes neovascularization, improving blood supply to a region of the tendon that is metabolically active but poorly vascularized.

Shockwave therapy also addresses the neurological component of chronic patellar tendon pain. The acoustic pulses reduce concentrations of Substance P, a pain-signaling neuropeptide, in the treated tissue. This can help break the pain-avoidance cycle where patients alter their movement patterns to avoid knee pain, which leads to abnormal loading, which perpetuates the tendinopathy.

Both focused and radial shockwave are used for patellar tendinopathy. The inferior pole of the patella is a relatively accessible, superficial target, making it suitable for both modalities. Some providers use focused ESWT for precise targeting of the tendon-bone junction and radial ESWT to treat the broader proximal tendon area.

What the Research Says

The evidence base for shockwave therapy in patellar tendinopathy is growing, with several controlled trials and systematic reviews supporting its use in chronic cases.

Zwerver et al., 2011 (British Journal of Sports Medicine): This double-blind, randomized controlled trial evaluated focused ESWT in 62 athletes with patellar tendinopathy who were still competing. At 22-week follow-up, the study found no significant difference between ESWT and placebo in athletes who continued to play through treatment. However, the study’s authors noted that continuing high-impact training during treatment likely limited the effectiveness of ESWT, and subsequent research has shown better outcomes in patients who modify their activity level during treatment.

Wang et al., 2007 (American Journal of Sports Medicine): Wang compared focused ESWT to conservative treatment (rest, physical therapy, NSAIDs) in 50 patients with chronic patellar tendinopathy. At two to three year follow-up, the ESWT group showed significantly better outcomes on multiple measures: 73.5% of the shockwave group achieved excellent or good results compared to 52% in the conservative group. Notably, pain and function scores continued to improve between the one-year and two-year follow-up assessments.

Vetrano et al., 2013 (American Journal of Sports Medicine): This randomized trial compared focused ESWT to PRP injection in 46 athletes with chronic patellar tendinopathy. At 6 and 12 months, both groups showed significant improvement, with PRP showing a slight advantage at 6 months but comparable outcomes at 12 months. The study supports both treatments as viable non-surgical options, with shockwave having the advantage of being non-invasive.

Peers et al., 2003 (Clinical Journal of Sport Medicine): Peers evaluated radial ESWT in 27 patients with chronic patellar tendinopathy and reported significant improvements in pain and function at six-month follow-up. The Tegner activity score — measuring the patient’s ability to return to sport — improved significantly in the treatment group.

van der Worp et al., 2014 (British Journal of Sports Medicine, systematic review): This systematic review examined all available evidence for shockwave therapy in patellar tendinopathy and concluded that there is limited-to-moderate evidence supporting ESWT. The review highlighted that outcomes are best when shockwave is combined with a structured rehabilitation program and when patients modify their activity levels during treatment.

What to Expect During Treatment

A shockwave therapy session for patellar tendinopathy takes about 10 to 15 minutes of active treatment and is performed in an outpatient setting.

Your provider will start by examining your knee to confirm the location of maximum tenderness at the inferior pole of the patella. You will be positioned seated or lying down with your knee slightly bent (approximately 20-30 degrees of flexion), which opens the space between the kneecap and the shinbone and makes the proximal patellar tendon more accessible.

Ultrasound coupling gel is applied to the front of the knee, and the shockwave applicator is placed directly over the tender area at the base of the kneecap. Treatment begins at a low energy setting and increases gradually based on your feedback.

You will feel a firm, repetitive tapping or pulsing directly over the patellar tendon. The sensation is typically uncomfortable to moderately painful over the most damaged area. Most patients find it tolerable, especially as they acclimate over the first few hundred impulses. A standard session delivers 2,000 to 2,500 impulses for radial shockwave or 1,500 to 2,000 for focused shockwave.

Your provider may move the applicator slightly during the session to treat different areas of the proximal tendon and the tendon-bone interface. Some providers use real-time ultrasound guidance to precisely target areas of tendon thickening or structural change.

After the session, you can walk normally. Mild aching or soreness around the kneecap is expected for 24 to 48 hours. Most providers advise avoiding jumping, deep squats, and heavy leg press for two to three days after each session.

Number of Sessions & Recovery Timeline

Standard protocols for patellar tendinopathy:

Radial shockwave (rESWT): Three to five sessions, spaced one week apart. This is the most commonly used outpatient protocol.

Focused shockwave (fESWT): Three to four sessions, spaced one to two weeks apart at higher energy levels.

Recovery timeline:

• Days 1-3 after each session: Mild to moderate soreness at the front of the knee, particularly with stair climbing or squatting. Avoid anti-inflammatory medications (NSAIDs like ibuprofen or naproxen) throughout the treatment course, as they may blunt the healing response.
• Weeks 1-3: Gradual reduction in the hallmark “start-up pain” — the stiffness and discomfort at the beginning of activity that eases with warming up. Some patients experience a temporary increase in symptoms early in treatment; this is a normal part of the healing process.
• Weeks 4-8: Progressive improvement in load tolerance. Activities like stair climbing, squatting, and light jogging typically become less painful. This is when most patients begin to feel a meaningful shift.
• Weeks 8-12: Significant improvement in most patients. Return to sport or higher-intensity activity can usually begin under provider guidance.
• 3-6 months: Continued tendon remodeling. Full return to demanding jumping sports may take this long, particularly for athletes with severe or long-standing tendinopathy.

Essential rehabilitation component: Shockwave therapy for patellar tendinopathy should not be used in isolation. Evidence consistently shows that combining ESWT with a structured loading program — particularly heavy slow resistance training (HSR) or eccentric decline squats — produces the best outcomes. Your provider or physical therapist should prescribe a specific exercise program to complement your shockwave treatment.

Cost & Insurance Coverage

Shockwave therapy for patellar tendinopathy typically costs $250 to $500 per session. A full course of three to five sessions ranges from $750 to $2,500, depending on geographic location, device type, and provider.

Insurance coverage: Because ESWT for patellar tendinopathy is off-label, insurance coverage is rare. Most patients pay out of pocket. Some commercial insurers may consider coverage on an exception basis if you can document prolonged symptoms, failed conservative treatment, and a provider recommendation that the alternative is surgical intervention.

Cost perspective for athletes: For competitive athletes, the relevant cost comparison includes not just the price of treatment but the opportunity cost of extended time away from sport. Patellar tendon surgery requires 4 to 6 months of rehabilitation before return to jumping sports, plus the inherent risks of any surgical procedure. A full course of shockwave therapy — even at the higher end of the price range — represents a fraction of the cost and downtime.

Payment options to explore:

• HSA or FSA funds (eligible as a medical expense)
• Package pricing from your provider (many offer discounts for a full course paid upfront)
• Superbill submission to your insurer for potential out-of-network reimbursement

See our shockwave therapy cost guide for a broader comparison across conditions and locations.

Who Is a Good Candidate?

Shockwave therapy for patellar tendinopathy is designed for patients with chronic symptoms that have not responded to a reasonable course of conservative treatment. You may be a good candidate if:

• You have had anterior knee pain localized to the inferior pole of the patella for at least three months
• You have tried rest, physical therapy (including eccentric exercises), and activity modification without adequate improvement
• Your pain limits your ability to jump, squat, run, or participate in sport
• You want a non-invasive alternative before considering surgery or injections
• Imaging (ultrasound or MRI) confirms tendon thickening or structural changes consistent with tendinopathy

Important consideration — activity modification matters: The Zwerver 2011 study showed that shockwave therapy was less effective in athletes who continued unrestricted training during treatment. Willingness to temporarily reduce jumping and high-impact loading during the treatment period significantly improves the likelihood of a good outcome. This does not mean complete rest — rather, a structured reduction in tendon-loading activities.

Conditions that may reduce effectiveness:

• Complete patellar tendon tears (requires surgical evaluation, not shockwave)
• Anterior knee pain from other causes — patellofemoral syndrome, fat pad impingement, plica syndrome — that mimic patellar tendinopathy but involve different structures
• Extremely short symptom duration (less than six weeks) — conservative measures should be tried first

Contraindications — shockwave therapy should NOT be used if you have:

• A bleeding disorder or are taking anticoagulant medication
• An active infection at or near the knee
• A tumor or malignancy in the treatment area
• An open growth plate at the knee (relevant for adolescents — discuss with your provider, as Osgood-Schlatter disease and Sinding-Larsen-Johansson syndrome have different treatment pathways)
• Had a corticosteroid injection into or around the patellar tendon within the past six weeks (corticosteroid injections into the patellar tendon are generally discouraged due to rupture risk)

If you have been dealing with stubborn patellar tendon pain that will not respond to rest and rehab, shockwave therapy is a well-supported non-surgical option.

Learn More

Explore our complete guide to shockwave therapy conditions or browse our latest research and articles to learn more about ESWT treatment options.

References

1. Zwerver J, Hartgens F, van den Akker-Scheek I, de Vos RJ, Diercks RL. No effect of extracorporeal shockwave therapy on patellar tendinopathy in jumping athletes during the competitive season: a randomized clinical trial. Am J Sports Med. 2011;39(6):1191-1199. PubMed

2. Wang CJ, Ko JY, Chan YS, Weng LH, Hsu SL. Extracorporeal shockwave for chronic patellar tendinopathy. Am J Sports Med. 2007;35(6):972-978. PubMed

3. Vetrano M, Castorina A, Vulpiani MC, Baldini R, Pavan A, Ferretti A. Platelet-rich plasma versus focused shock waves in the treatment of jumper’s knee in athletes. Am J Sports Med. 2013;41(4):795-803. PubMed

4. Peers KH, Lysens RJ, Brys P, Bellemans J. Cross-sectional outcome analysis of athletes with chronic patellar tendinopathy treated surgically and by extracorporeal shock wave therapy. Clin J Sport Med. 2003;13(2):79-83. PubMed

5. van der Worp H, van den Akker-Scheek I, van Schie H, Zwerver J. ESWT for tendinopathy: technology and clinical implications. Knee Surg Sports Traumatol Arthrosc. 2013;21(6):1451-1458. PubMed